EIB
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union. The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds; equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds. The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises. EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors. European Investment Bank was founded in 1958 and is based in Luxembourg.
AT&S is a Europe-based printed circuit board manufacturer focused on high-end printed circuit board technology. Depending on technological and economic requirements, the company offers the widest possible range of printed circuit boards specially tailored to customers’ needs such as double-sided plated-through, multi-layer, high density interconnection and laser-drilled, insulated metallic substrate, flexible, rigid-flex, and semi-flexible. The core businesses of AT&S are mobile devices and substrates, automotive, industrial, medical, aviation, and advanced packaging. It has approximately 7,300 employees, of which around 1,200 are in Austria. In the 2013 and 2014 financial year AT&S’s sales revenues totaled 590 million euros, and earnings before interest and tax were 53.9 million euros. AT&S is headquartered in Leoben, Austria.
USound GmbH is an innovative audio technology company based in Graz, Austria, founded in 2014. The company specializes in designing, developing, and manufacturing audio systems that leverage Micro ElectroMechanical Systems (MEMS) technology for mobile applications. USound produces advanced MEMS micro speakers that are integrated into a variety of products, including smartphones, headphones, and hearing aids. Their audio systems combine electronic circuits, MEMS micro speakers, and passive components into compact devices, enhancing sound experiences and enabling new interactions with audio. As a fabless company, USound outsources its research and development, as well as manufacturing, to leading industrial partners, allowing it to focus on advancing its innovative technology.
Cortical.io AG, founded in 2011 and based in Vienna, Austria, specializes in developing natural language processing (NLP) solutions utilizing its proprietary semantic folding technology. This innovative approach allows for more effective handling and analysis of large volumes of unstructured text data. The company offers a range of products, including the Cortical engine for text processing, Cortical.io Contract Intelligence for managing legal documents, and the retina library and API for searching and analyzing extensive text data repositories. Cortical.io's AI-driven solutions can be quickly trained without supervision to adapt to the specific vocabulary of various business domains and support multiple languages. Its technology has been implemented by several Fortune 100 companies across diverse use cases, and the company collaborates with strategic partners such as PwC Germany. Additionally, Cortical.io holds a broad general license for Numenta's HTM technology and has offices in both the United States and Europe.
Bitmovin Inc specializes in online streaming solutions and server encoding systems, offering a range of products designed to enhance video delivery and user experience. The company's key offerings include a cloud-based transcoding platform known as bitcodin, which supports adaptive streaming for MPEG-DASH and Apple HLS, as well as BITDASH, a suite of optimized clients for various devices. Additionally, Bitmovin provides an Encoding API for real-time content encoding, a Player for delivering video to streaming devices, and analytics tools that help increase viewer engagement through actionable insights. Founded in 2012 and based in San Francisco, California, with an additional office in Klagenfurt, Austria, Bitmovin emerged from the Alpen-Adria-University Klagenfurt and continues to engage in research and standardization efforts in the multimedia sector. The company maintains a strategic partnership with Intertrust Technologies Corporation and has attracted investment from notable firms such as Atomico and YCombinator.
APEIRON Biologics AG is engaged in the discovery, development, and commercialization of innovative immunotherapies aimed at treating cancer and respiratory diseases. Founded in 2005 and based in Vienna, Austria, the company focuses on novel approaches to enhance immune response. Its pipeline includes several key drug candidates: APN01 for COVID-19, APN401 which utilizes an autologous cellular therapy to target the Cbl-b checkpoint for improved immune reactivity, APN431 that employs short cell-penetrating peptides to inhibit Cbl-b protein, and APN421, an oral discovery program aimed at a new target to boost the activity of immune cells such as CD4+ and CD8+ T cells and natural killer cells. APEIRON has established a strong patent portfolio and collaborates with prominent pharmaceutical companies and academic institutions to validate its development expertise.
Valneva SE is a specialty vaccine company dedicated to the development and commercialization of vaccines for infectious diseases that lack adequate solutions. The company offers two commercial vaccines for travelers: IXIARO/JESPECT, which protects against Japanese encephalitis, and DUKORAL, aimed at preventing cholera and certain types of diarrhea. Valneva is also advancing several vaccine candidates, including the only developmental vaccine for Lyme disease and a single-shot vaccine for chikungunya. Founded in 1999, Valneva operates in multiple countries, including Austria, Canada, France, Sweden, the United Kingdom, and the United States. The company is involved in a collaboration with Dynavax Technologies Corporation to further vaccine development for COVID-19. Valneva's focus is on addressing urgent public health needs through innovative vaccine solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.